Biomaterials for Local, Controlled Drug Delivery to the Injured Spinal Cord
Affecting approximately 17,000 new people each year, spinal cord injury (SCI) is a devastating injury that leads to permanent paraplegia or tetraplegia. Current pharmacological approaches are limited in their ability to ameliorate this injury pathophysiology, as many are not delivered locally, for a...
Main Authors: | Alexis M. Ziemba, Ryan J. Gilbert |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2017-05-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fphar.2017.00245/full |
Similar Items
-
Hydrogels as delivery systems for spinal cord injury regeneration
by: D. Silva, et al.
Published: (2021-01-01) -
Natural biomaterials for enhanced oligodendrocyte differentiation and spinal cord injury repair
by: Geissler, Sydney Amelia
Published: (2015) -
The Role of Biomaterials as Angiogenic Modulators of Spinal Cord Injury: Mimetics of the Spinal Cord, Cell and Angiogenic Factor Delivery Agents
by: Luís A. Rocha, et al.
Published: (2018-02-01) -
Role of biomaterials in neurorestoration after spinal cord injuries
by: Ioana Stanescu, et al.
Published: (2016-05-01) -
Biomaterial-Supported Cell Transplantation Treatments for Spinal Cord Injury: Challenges and Perspectives
by: Shengwen Liu, et al.
Published: (2018-01-01)